Research article · 30 Sep 2021
Conference abstractPublished 8 May 2017
Hydroxyurea, an effective therapy to avoid splenectomy in sickle cell disease and thalassemia: Single institute experience in Saudi Arabia
King Abdulaziz University, KSA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Background & Aim: Spleen plays an important part in the immune system which helps the body to fight against infection and has a major role in children. Splenectomy has been decline in hemoglobin disorders in recent years. Aim of this study is to assess the role of hydroxyurea and to eliminate the risk of splenectomy in sickle cell disease (SCD) and thalassemia at our medical center. Methods: Total of 54 patients enrolled in the study from 2004 to 2016 at King Abdulaziz University Hospital, Faculty of Medicine and King Abdulaziz University, Saudi Arabia. 25 sickle cell disease (SCD), 17 thalassemia major (TM) were suboptimal transfusion dependents and hypersplenism, 12 thalassemia inter media (TI). Results: Risk of splenectomy has been avoided in 24/25 SCD, 15/17 in TM and 12/12 in TI. Conclusion: Hydroxyurea is an effective and safe therapy can eliminate risk of splenectomy in SCD and thalassemia. Recent studies and meta-analysis showed that hydroxyurea is safe and non-carcinogenic.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Research article · 2017
Factors Influencing the Outcome of Hematopoietic Stem Cell Transplantation in Pediatric Acute Myeloid Leukemia: Single Institution Results from Saudi Arabia
Conference abstract · 24 Jan 2022
Alpha-Thalassemia patterns in Saudi population: a single-center study from Jeddah city, Saudi Arabia
Conference abstract · 13 Dec 2018
Hydroxyurea therapy in the pediatric patient with sickle cell disease: Barriers to the implementation of hydroxyurea in sub-Saharan Africa
Research article · 2014
Adherence to Hydroxyurea Therapy in Patients with Sickle Cell Disease at King Khalid University Hospital in Riyadh
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- BylineArticles whose byline prints “Soad K Al Jaouni”
